DIAGENS-B Surges Over 13% in Morning Trading as Medical AI Innovation Ecosystem Takes Shape

DIAGENS-B (02526) shares surged over 13% in early trading, and as of press time, were up 10.87% to HK$359, with a turnover of HK$6.8048 million.

On the news front, DIAGENS recently announced the official launch of its independently developed iMedLoop global medical imaging data platform. iMedLoop integrates the iMedImage medical imaging base model, the iMedStudio intelligent annotation tool, and the iMedMaaS online model training and publishing platform, forming a complete closed loop around medical data aggregation and governance, intelligent annotation, model training, model publishing, and clinical application.

Meanwhile, DIAGENS Technology has formally signed a strategic cooperation framework agreement with the Hangzhou Data Exchange and the Hangzhou Data Element Innovation Center. It is reported that substantive business results have already been achieved through this tripartite collaboration. DIAGENS Technology has successfully completed a cooperation on municipal hospital model training data with the Hangzhou Data Exchange and the Hangzhou Data Element Innovation Center, providing high-quality, compliant data support for the precise iteration and scenario-based deployment of medical AI models, effectively transforming medical data elements from resource reserves into realized value.